Search
Close this search box.

Hemlibra to be publicly funded!

We are delighted that the Federal Minister for Health, The Hon. Greg Hunt MP, has announced today that emicizumab (Hemlibra®) will be publicly funded as a treatment for Australians with haemophilia.
 
Hemlibra® is a treatment that can reduce or stop bleeding in people with severe or moderate haemophilia A with and without inhibitors.
 
Gavin Finkelstein, HFA President, said, 'this is great news for our community. We are pleased all governments in Australia have agreed to fund their share of the costs of this treatment product for those in our community who need it'.
 
Minister Hunt said in his press release that regular supply of Hemlibra® is expected to be available by December 2020.

Click here to read Minister Hunt's press release

Latest stories

Girl playing in garden. Image by Emma Bauso for Pexels.

Growing up with Glanzmann thrombasthenia 

Elizabeth’s teenage daughter Grace has Glanzmann thrombasthenia. Elizabeth spoke with HFA about what it was like to find that your child has a very rare bleeding disorder and their family experiences as Grace grows up.

Read More
Skip to content